Xofigo Solution For Injection 1000Kbq Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Xofigo: Solution for injection (1000kBq)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

RADIUM-223 DICHLORIDE (ray dee um) is a radiopharmaceutical drug. This medicine allows radiation to target bone metastases from prostate cancer and prevent fractures and other bone problems caused by cancer bone metastases.

In-Depth Information

Xofigo 1000 kBq/mL Solution for Injection

NDC: 504190208
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Prostate Cancer

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Store below 104 degrees F
Discard product if it contains particulate matter, is cloudy, or discolored
Store in original container
Discard unused portion. Do not store for later use.
Xofigo 1000 kBq/mL Solution for Injection

Reported Side Effects for Xofigo 1000 kBq/mL Solution for Injection

Secondary Malignancy Incidence:
<1.0%*
Severity: MODERATE
Onset: DELAYED
Skin Redness Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Loose Stools Incidence:
>2.0%*
Severity: SEVERE
Onset: EARLY
Infection Incidence:
>2.0%*
Severity: SEVERE
Onset: DELAYED
Fluid Retention Incidence:
>2.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
>2.0%*
Severity: SEVERE
Onset: EARLY
Upset Stomach Incidence:
>2.0%*
Severity: SEVERE
Onset: EARLY
Dehydration Incidence:
>3.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

SECOND Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

THIRD Trimester

Class X - Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks. The use of the product is contraindicated in women who are or may become pregnant.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Xofigo

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5